Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-07

AUTHORS

Ikuo Yokoyama, Shin-ichi Momomura, Tohru Ohtake, Katsunori Yonekura, Yusuke Inoue, Naoshi Kobayakawa, Teruhiko Aoyagi, Seiryo Sugiura, Jun-ichi Nishikawa, Yasuhito Sasaki, Masao Omata

ABSTRACT

. Improvement in left ventricular (LV) function in patients with idiopathic dilated cardiomyopathy (DCM) by medical treatment has been suggested. Thus, it is important to evaluate which patients will respond to medical therapy. Positron emission tomography (PET) with fluorine-18 fluoro-2-deoxyglucose (FDG) and cardiac catheterization were performed in 20 patients with DCM before the initiation of medical therapy. The regional myocardial glucose utilization rate (rMGU) was measured with FDG PET. Subjects were divided into two groups, group 1 (event-free patients, n=10) and group 2 (clinical cardiac events, n=10). Haemodynamic and PET parameters before the initiation of medication were compared between the two groups and between patients with and patients without improvement in LV function. Ejection fraction (EF) was significantly higher in group 1 (35.8%±9.0%) than in group 2 (24.8%±7.0%) and LV end-diastolic pressure (LVEDP) was significantly lower in group 1 (8.4±1.7 mmHg) than in group 2 (11.6±3.5 mmHg). Average rMGU (mg min–1 100 g–1) was similar in group 1 (11.2±2.5 mg min–1 100 g–1) and group 2 (11.2±2.9 mg min–1 100 g–1), while %CV of rMGU was significantly lower in group 1 (11.1%±6.3%) than in group 2 (29.9%±13.9%, P<0.01). Furthermore, LV function normalized in seven patients in group 1. In these seven patients, EF (35.1%±10.9%), LVEDP (8.2±2.0 mmHg) and average rMGU (11.8±2.7 mg min–1 100 g–1) were comparable with those in patients without LV functional improvement (EF: 31.6%±9.1%; LVEDP: 10.7±3.3 mmHg; average rMGU: 10.8± 2.7 mg min–1 100 g–1). However,% CV of rMGU in patients with LV functional improvement (9.6%±5.6%) was significantly lower than in those without such improvement (26.3%±14.1%, P<0.01). %CV of rMGU <13.6% predicted prognosis with a sensitivity of 80%, a specificity of 100% and an accuracy of 90%. %CV of rMGU <13.6% also predicted improvement in LV function, with a sensitivity of 75%, a specificity of 92% and an accuracy of 85%. However, EF failed to predict improvement of LV function. In is concluded that homogeneous myocardial glucose utilization rate can predict both prognosis and improvement in LV function achieved by medical therapy in patients with DCM. More... »

PAGES

736-743

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002590050277

DOI

http://dx.doi.org/10.1007/s002590050277

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011663157

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9662596


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiomyopathy, Dilated", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, Emission-Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Function, Left", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoyama", 
        "givenName": "Ikuo", 
        "id": "sg:person.01355412055.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355412055.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Momomura", 
        "givenName": "Shin-ichi", 
        "id": "sg:person.01242732453.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242732453.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohtake", 
        "givenName": "Tohru", 
        "id": "sg:person.01253520654.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253520654.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yonekura", 
        "givenName": "Katsunori", 
        "id": "sg:person.0746234355.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746234355.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inoue", 
        "givenName": "Yusuke", 
        "id": "sg:person.010476276272.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476276272.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobayakawa", 
        "givenName": "Naoshi", 
        "id": "sg:person.01211752724.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211752724.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aoyagi", 
        "givenName": "Teruhiko", 
        "id": "sg:person.010646460075.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010646460075.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugiura", 
        "givenName": "Seiryo", 
        "id": "sg:person.01277502614.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277502614.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishikawa", 
        "givenName": "Jun-ichi", 
        "id": "sg:person.012700705542.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012700705542.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sasaki", 
        "givenName": "Yasuhito", 
        "id": "sg:person.011417422332.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011417422332.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Omata", 
        "givenName": "Masao", 
        "id": "sg:person.0775700471.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-07", 
    "datePublishedReg": "1998-07-01", 
    "description": "Abstract. Improvement in left ventricular (LV) function in patients with idiopathic dilated cardiomyopathy (DCM) by medical treatment has been suggested. Thus, it is important to evaluate which patients will respond to medical therapy. Positron emission tomography (PET) with fluorine-18 fluoro-2-deoxyglucose (FDG) and cardiac catheterization were performed in 20 patients with DCM before the initiation of medical therapy. The regional myocardial glucose utilization rate (rMGU) was measured with FDG PET. Subjects were divided into two groups, group 1 (event-free patients, n=10) and group 2 (clinical cardiac events, n=10). Haemodynamic and PET parameters before the initiation of medication were compared between the two groups and between patients with and patients without improvement in LV function. Ejection fraction (EF) was significantly higher in group 1 (35.8%\u00b19.0%) than in group 2 (24.8%\u00b17.0%) and LV end-diastolic pressure (LVEDP) was significantly lower in group 1 (8.4\u00b11.7\u00a0mmHg) than in group 2 (11.6\u00b13.5\u00a0mmHg). Average rMGU (mg min\u20131 100\u00a0g\u20131) was similar in group 1 (11.2\u00b12.5\u00a0mg min\u20131 100\u00a0g\u20131) and group 2 (11.2\u00b12.9\u00a0mg min\u20131 100\u00a0g\u20131), while %CV of rMGU was significantly lower in group 1 (11.1%\u00b16.3%) than in group 2 (29.9%\u00b113.9%, P<0.01). Furthermore, LV function normalized in seven patients in group 1. In these seven patients, EF (35.1%\u00b110.9%), LVEDP (8.2\u00b12.0\u00a0mmHg) and average rMGU (11.8\u00b12.7\u00a0mg min\u20131 100\u00a0g\u20131) were comparable with those in patients without LV functional improvement (EF: 31.6%\u00b19.1%; LVEDP: 10.7\u00b13.3\u00a0mmHg; average rMGU: 10.8\u00b1 2.7\u00a0mg min\u20131 100\u00a0g\u20131). However,% CV of rMGU in patients with LV functional improvement (9.6%\u00b15.6%) was significantly lower than in those without such improvement (26.3%\u00b114.1%, P<0.01). %CV of rMGU <13.6% predicted prognosis with a sensitivity of 80%, a specificity of 100% and an accuracy of 90%. %CV of rMGU <13.6% also predicted improvement in LV function, with a sensitivity of 75%, a specificity of 92% and an accuracy of 85%. However, EF failed to predict improvement of LV function. In is concluded that homogeneous myocardial glucose utilization rate can predict both prognosis and improvement in LV function achieved by medical therapy in patients with DCM.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002590050277", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "LV end-diastolic pressure", 
      "positron emission tomography", 
      "myocardial glucose utilization rate", 
      "LV functional improvement", 
      "left ventricular function", 
      "LV function", 
      "ejection fraction", 
      "group 1", 
      "group 2", 
      "medical therapy", 
      "glucose utilization rate", 
      "ventricular function", 
      "functional improvement", 
      "emission tomography", 
      "end-diastolic pressure", 
      "FDG positron emission tomography", 
      "initiation of medication", 
      "cardiac catheterization", 
      "PET parameters", 
      "medical treatment", 
      "patients", 
      "therapy", 
      "prognosis", 
      "tomography", 
      "utilization rate", 
      "DCM", 
      "catheterization", 
      "medications", 
      "haemodynamics", 
      "group", 
      "cardiomyopathy", 
      "initiation", 
      "specificity", 
      "improvement", 
      "treatment", 
      "subjects", 
      "sensitivity", 
      "rate", 
      "function", 
      "such improvements", 
      "role", 
      "pressure", 
      "fraction", 
      "cv", 
      "accuracy", 
      "parameters", 
      "rMGU", 
      "Average rMGU", 
      "CV of rMGU", 
      "homogeneous myocardial glucose utilization rate"
    ], 
    "name": "Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy", 
    "pagination": "736-743", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011663157"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002590050277"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9662596"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002590050277", 
      "https://app.dimensions.ai/details/publication/pub.1011663157"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_288.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002590050277"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002590050277'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002590050277'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002590050277'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002590050277'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      94 URIs      86 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002590050277 schema:about N0a1da11005cd4e95a8d1de3df4de0abb
2 N1a1130bbc13141969034e96d498c6337
3 N2837b59cc78942ea9587ee21493d3c5b
4 N369bc7eae4c24eb7a00e0a29934d1d7d
5 N40865e6069eb4498879548ca892e1991
6 N451cc024bfb44292a10547daba81a314
7 N66634af308254ffebbff82bb852368c2
8 N6cda38a1a38f4199b5e74ec68087d1c1
9 N83bad3174ac44627afa5eee4603c43b1
10 Naf7628c11b4d4ee6a13fae6286098aee
11 Nc4335a5a94994fc8bdc49b85784e903a
12 Nc8fbf554156442d5bfa58f908569dd48
13 Nd0d8a759be78418bb76b7fdbd046817e
14 Ndac126b7501a43c488f67aa1182f1c21
15 Ne457ef16e1d8453aa1ad2a55c65d65ea
16 Ne4ed8882ad3c42a29af522020e9061aa
17 Nece3c0e511e249bab662efe012ebc63c
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N7ebd2a555ef2415baee8a06c10fa4511
21 schema:datePublished 1998-07
22 schema:datePublishedReg 1998-07-01
23 schema:description Abstract. Improvement in left ventricular (LV) function in patients with idiopathic dilated cardiomyopathy (DCM) by medical treatment has been suggested. Thus, it is important to evaluate which patients will respond to medical therapy. Positron emission tomography (PET) with fluorine-18 fluoro-2-deoxyglucose (FDG) and cardiac catheterization were performed in 20 patients with DCM before the initiation of medical therapy. The regional myocardial glucose utilization rate (rMGU) was measured with FDG PET. Subjects were divided into two groups, group 1 (event-free patients, n=10) and group 2 (clinical cardiac events, n=10). Haemodynamic and PET parameters before the initiation of medication were compared between the two groups and between patients with and patients without improvement in LV function. Ejection fraction (EF) was significantly higher in group 1 (35.8%±9.0%) than in group 2 (24.8%±7.0%) and LV end-diastolic pressure (LVEDP) was significantly lower in group 1 (8.4±1.7 mmHg) than in group 2 (11.6±3.5 mmHg). Average rMGU (mg min–1 100 g–1) was similar in group 1 (11.2±2.5 mg min–1 100 g–1) and group 2 (11.2±2.9 mg min–1 100 g–1), while %CV of rMGU was significantly lower in group 1 (11.1%±6.3%) than in group 2 (29.9%±13.9%, P<0.01). Furthermore, LV function normalized in seven patients in group 1. In these seven patients, EF (35.1%±10.9%), LVEDP (8.2±2.0 mmHg) and average rMGU (11.8±2.7 mg min–1 100 g–1) were comparable with those in patients without LV functional improvement (EF: 31.6%±9.1%; LVEDP: 10.7±3.3 mmHg; average rMGU: 10.8± 2.7 mg min–1 100 g–1). However,% CV of rMGU in patients with LV functional improvement (9.6%±5.6%) was significantly lower than in those without such improvement (26.3%±14.1%, P<0.01). %CV of rMGU <13.6% predicted prognosis with a sensitivity of 80%, a specificity of 100% and an accuracy of 90%. %CV of rMGU <13.6% also predicted improvement in LV function, with a sensitivity of 75%, a specificity of 92% and an accuracy of 85%. However, EF failed to predict improvement of LV function. In is concluded that homogeneous myocardial glucose utilization rate can predict both prognosis and improvement in LV function achieved by medical therapy in patients with DCM.
24 schema:genre article
25 schema:inLanguage en
26 schema:isAccessibleForFree false
27 schema:isPartOf N217ab11395614e86b06e4ffbb5dce453
28 N5b00650bd4974238b2d8fa8a994608d9
29 sg:journal.1297401
30 schema:keywords Average rMGU
31 CV of rMGU
32 DCM
33 FDG positron emission tomography
34 LV end-diastolic pressure
35 LV function
36 LV functional improvement
37 PET parameters
38 accuracy
39 cardiac catheterization
40 cardiomyopathy
41 catheterization
42 cv
43 ejection fraction
44 emission tomography
45 end-diastolic pressure
46 fraction
47 function
48 functional improvement
49 glucose utilization rate
50 group
51 group 1
52 group 2
53 haemodynamics
54 homogeneous myocardial glucose utilization rate
55 improvement
56 initiation
57 initiation of medication
58 left ventricular function
59 medical therapy
60 medical treatment
61 medications
62 myocardial glucose utilization rate
63 parameters
64 patients
65 positron emission tomography
66 pressure
67 prognosis
68 rMGU
69 rate
70 role
71 sensitivity
72 specificity
73 subjects
74 such improvements
75 therapy
76 tomography
77 treatment
78 utilization rate
79 ventricular function
80 schema:name Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy
81 schema:pagination 736-743
82 schema:productId N0e44da550f724d96951b9a13ed907bbb
83 N61c47003cd0b4c17aed3f3345b965645
84 Nb33995fac8284a2b936622ea5d2b4c92
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011663157
86 https://doi.org/10.1007/s002590050277
87 schema:sdDatePublished 2021-12-01T19:10
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher N4e1f418dcaf04b17841447efcb094705
90 schema:url https://doi.org/10.1007/s002590050277
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N0a1da11005cd4e95a8d1de3df4de0abb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Humans
96 rdf:type schema:DefinedTerm
97 N0e44da550f724d96951b9a13ed907bbb schema:name dimensions_id
98 schema:value pub.1011663157
99 rdf:type schema:PropertyValue
100 N1a1130bbc13141969034e96d498c6337 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Adult
102 rdf:type schema:DefinedTerm
103 N217ab11395614e86b06e4ffbb5dce453 schema:volumeNumber 25
104 rdf:type schema:PublicationVolume
105 N2837b59cc78942ea9587ee21493d3c5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Risk Factors
107 rdf:type schema:DefinedTerm
108 N369bc7eae4c24eb7a00e0a29934d1d7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Radiopharmaceuticals
110 rdf:type schema:DefinedTerm
111 N3c6e4ef04fca44bf9498e9cd0c777360 rdf:first sg:person.012700705542.16
112 rdf:rest Ne3f3a90febe6461ebac8c452f988b2ca
113 N40865e6069eb4498879548ca892e1991 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Middle Aged
115 rdf:type schema:DefinedTerm
116 N451cc024bfb44292a10547daba81a314 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Myocardium
118 rdf:type schema:DefinedTerm
119 N48d36446f2e04112bf656af39d80e1fa rdf:first sg:person.0775700471.08
120 rdf:rest rdf:nil
121 N4e1f418dcaf04b17841447efcb094705 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N4fdc6eeb050545eeadda453e1cabe1f0 rdf:first sg:person.01242732453.82
124 rdf:rest N52c16403887b441d84c67c6a6759a1d5
125 N52c16403887b441d84c67c6a6759a1d5 rdf:first sg:person.01253520654.94
126 rdf:rest N8b91259ce886489fa57451f141ac3d7e
127 N5b00650bd4974238b2d8fa8a994608d9 schema:issueNumber 7
128 rdf:type schema:PublicationIssue
129 N61c47003cd0b4c17aed3f3345b965645 schema:name pubmed_id
130 schema:value 9662596
131 rdf:type schema:PropertyValue
132 N66634af308254ffebbff82bb852368c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Aged
134 rdf:type schema:DefinedTerm
135 N6cda38a1a38f4199b5e74ec68087d1c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Ventricular Function, Left
137 rdf:type schema:DefinedTerm
138 N7ebd2a555ef2415baee8a06c10fa4511 rdf:first sg:person.01355412055.69
139 rdf:rest N4fdc6eeb050545eeadda453e1cabe1f0
140 N83bad3174ac44627afa5eee4603c43b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Tomography, Emission-Computed
142 rdf:type schema:DefinedTerm
143 N8b91259ce886489fa57451f141ac3d7e rdf:first sg:person.0746234355.31
144 rdf:rest Nbc6cd14ed2254d068e6103baf30d04dc
145 Naf7628c11b4d4ee6a13fae6286098aee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Prognosis
147 rdf:type schema:DefinedTerm
148 Nb33995fac8284a2b936622ea5d2b4c92 schema:name doi
149 schema:value 10.1007/s002590050277
150 rdf:type schema:PropertyValue
151 Nbaf239b6ae6143668ac47dc60fcaecca rdf:first sg:person.010646460075.48
152 rdf:rest Nd61ea6c59a6847c8b4977b04a7f8d321
153 Nbc6cd14ed2254d068e6103baf30d04dc rdf:first sg:person.010476276272.43
154 rdf:rest Ndac7fb7aa37a41899f79a46a5279bb34
155 Nc4335a5a94994fc8bdc49b85784e903a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Fluorine Radioisotopes
157 rdf:type schema:DefinedTerm
158 Nc8fbf554156442d5bfa58f908569dd48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Male
160 rdf:type schema:DefinedTerm
161 Nd0d8a759be78418bb76b7fdbd046817e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Cardiomyopathy, Dilated
163 rdf:type schema:DefinedTerm
164 Nd61ea6c59a6847c8b4977b04a7f8d321 rdf:first sg:person.01277502614.69
165 rdf:rest N3c6e4ef04fca44bf9498e9cd0c777360
166 Ndac126b7501a43c488f67aa1182f1c21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Glucose
168 rdf:type schema:DefinedTerm
169 Ndac7fb7aa37a41899f79a46a5279bb34 rdf:first sg:person.01211752724.24
170 rdf:rest Nbaf239b6ae6143668ac47dc60fcaecca
171 Ne3f3a90febe6461ebac8c452f988b2ca rdf:first sg:person.011417422332.20
172 rdf:rest N48d36446f2e04112bf656af39d80e1fa
173 Ne457ef16e1d8453aa1ad2a55c65d65ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Hemodynamics
175 rdf:type schema:DefinedTerm
176 Ne4ed8882ad3c42a29af522020e9061aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Female
178 rdf:type schema:DefinedTerm
179 Nece3c0e511e249bab662efe012ebc63c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Fluorodeoxyglucose F18
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:journal.1297401 schema:issn 1619-7070
189 1619-7089
190 schema:name European Journal of Nuclear Medicine and Molecular Imaging
191 schema:publisher Springer Nature
192 rdf:type schema:Periodical
193 sg:person.010476276272.43 schema:affiliation grid-institutes:grid.26999.3d
194 schema:familyName Inoue
195 schema:givenName Yusuke
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476276272.43
197 rdf:type schema:Person
198 sg:person.010646460075.48 schema:affiliation grid-institutes:grid.26999.3d
199 schema:familyName Aoyagi
200 schema:givenName Teruhiko
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010646460075.48
202 rdf:type schema:Person
203 sg:person.011417422332.20 schema:affiliation grid-institutes:grid.26999.3d
204 schema:familyName Sasaki
205 schema:givenName Yasuhito
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011417422332.20
207 rdf:type schema:Person
208 sg:person.01211752724.24 schema:affiliation grid-institutes:grid.26999.3d
209 schema:familyName Kobayakawa
210 schema:givenName Naoshi
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211752724.24
212 rdf:type schema:Person
213 sg:person.01242732453.82 schema:affiliation grid-institutes:grid.26999.3d
214 schema:familyName Momomura
215 schema:givenName Shin-ichi
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242732453.82
217 rdf:type schema:Person
218 sg:person.01253520654.94 schema:affiliation grid-institutes:grid.26999.3d
219 schema:familyName Ohtake
220 schema:givenName Tohru
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253520654.94
222 rdf:type schema:Person
223 sg:person.012700705542.16 schema:affiliation grid-institutes:grid.26999.3d
224 schema:familyName Nishikawa
225 schema:givenName Jun-ichi
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012700705542.16
227 rdf:type schema:Person
228 sg:person.01277502614.69 schema:affiliation grid-institutes:grid.26999.3d
229 schema:familyName Sugiura
230 schema:givenName Seiryo
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277502614.69
232 rdf:type schema:Person
233 sg:person.01355412055.69 schema:affiliation grid-institutes:grid.26999.3d
234 schema:familyName Yokoyama
235 schema:givenName Ikuo
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355412055.69
237 rdf:type schema:Person
238 sg:person.0746234355.31 schema:affiliation grid-institutes:grid.26999.3d
239 schema:familyName Yonekura
240 schema:givenName Katsunori
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746234355.31
242 rdf:type schema:Person
243 sg:person.0775700471.08 schema:affiliation grid-institutes:grid.26999.3d
244 schema:familyName Omata
245 schema:givenName Masao
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08
247 rdf:type schema:Person
248 grid-institutes:grid.26999.3d schema:alternateName The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP
249 The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP
250 schema:name The Department of Radiology University of Tokyo, University of Tokyo, Tokyo, Japan, JP
251 The Second Department of Internal Medicine University of Tokyo, University of Tokyo, Japan, JP
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...